Important information


Monoclonal Antibody to RANK (Receptor Activator of NF-kB)


100 μg / 0.5 mg/ml

Catalog number



514 €

Extended information

French translation


Data sheet

Contact us to request a Data sheet

Technical data

Contact us to request a Technical data


Use before expiry date given on the label


stored between 2°C and 8°C. Do not freeze.


If you buy Antibodies supplied by Genlantis they should be stored frozen at - 24°C for long term storage and for short term at + 5°C.


Our specialists recommend you to follow carefully the pre-registered instructions for Monoclonal Antibody to RANK (Receptor Activator of NF-kB)


To order Monoclonal Antibody to RANK (Receptor Activator of NF-kB), please use the Cat. Nr.ABI128 and submit your purchase order by email or by fax. A discount is available for larger or bulk quantities, please contact us for more information


Monoclonals of this antigen are available in different clones. Each murine monoclonal anibody has his own affinity specific for the clone. Mouse monoclonal antibodies are purified protein A or G and can be conjugated to FITC for flow cytometry or FACS and can be of different isotypes.


Monoclonal Antibody to RANK (Receptor Activator of NF-kB) are antibodies that are made by identical immune cells that are all clones of a unique parent cell. Monoclonal antibodies can have monovalent affinity, in that they bind to the same epitope (the part of an antigen that is recognized by the antibody).

Additional description

The receptors are ligand binding factors of type 1, 2 or 3 and protein-molecules that receive chemical-signals from outside a cell. When such chemical-signals couple or bind to a receptor, they cause some form of cellular/tissue-response, e.g. a change in the electrical-activity of a cell. In this sense, am olfactory receptor is a protein-molecule that recognizes and responds to endogenous-chemical signals, chemokinesor cytokines e.g. an acetylcholine-receptor recognizes and responds to its endogenous-ligand, acetylcholine. However, sometimes in pharmacology, the term is also used to include other proteins that are drug-targets, such as enzymes, transporters and ion-channels.